HUP0102816A3 - Pharmaceutical composition containg brivudine - Google Patents
Pharmaceutical composition containg brivudineInfo
- Publication number
- HUP0102816A3 HUP0102816A3 HU0102816A HUP0102816A HUP0102816A3 HU P0102816 A3 HUP0102816 A3 HU P0102816A3 HU 0102816 A HU0102816 A HU 0102816A HU P0102816 A HUP0102816 A HU P0102816A HU P0102816 A3 HUP0102816 A3 HU P0102816A3
- Authority
- HU
- Hungary
- Prior art keywords
- brivudine
- pharmaceutical composition
- composition containg
- containg
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2001MI000009A ITMI20010009A1 (it) | 2001-01-03 | 2001-01-03 | Composizioni farmaceutica contenente brivudina per la singola somministrazione giornaliera |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU0102816D0 HU0102816D0 (en) | 2001-09-28 |
| HUP0102816A2 HUP0102816A2 (en) | 2002-10-28 |
| HUP0102816A3 true HUP0102816A3 (en) | 2005-01-28 |
Family
ID=11446384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0102816A HUP0102816A3 (en) | 2001-01-03 | 2001-07-05 | Pharmaceutical composition containg brivudine |
Country Status (20)
| Country | Link |
|---|---|
| AT (1) | AT6141U1 (fr) |
| BE (1) | BE1014522A5 (fr) |
| CH (1) | CH695662A5 (fr) |
| CZ (1) | CZ20012464A3 (fr) |
| DK (1) | DK177084B1 (fr) |
| ES (1) | ES2192456B1 (fr) |
| FI (1) | FI20011446A7 (fr) |
| FR (1) | FR2818907B1 (fr) |
| GB (1) | GB2370771A (fr) |
| GR (1) | GR1004012B (fr) |
| HR (1) | HRPK20010345B3 (fr) |
| HU (1) | HUP0102816A3 (fr) |
| IE (1) | IE20010413A1 (fr) |
| IT (1) | ITMI20010009A1 (fr) |
| NL (1) | NL1018431C2 (fr) |
| PL (1) | PL348480A1 (fr) |
| PT (1) | PT102642B (fr) |
| SE (1) | SE0102309L (fr) |
| SK (1) | SK287043B6 (fr) |
| UA (1) | UA76402C2 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2239527B1 (es) * | 2004-03-01 | 2006-11-16 | M. Cruz Fernandez Gonzalez | Composicion farmacologica de uso topico para el tratamiento del herpes zoster. |
| CN113712928A (zh) * | 2021-09-29 | 2021-11-30 | 重庆市力扬医药开发有限公司 | 经口腔粘膜吸收的溴夫定药物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0104857A1 (fr) * | 1982-09-28 | 1984-04-04 | Beecham Group Plc | Dérivés de la déoxyuridine, leurs méthodes de préparation et leur emploi en médecine |
| IT1170232B (it) * | 1983-10-31 | 1987-06-03 | Anna Gioia Stendardi | Composizioni terapeutiche ad attivita' antivirale |
| US5446031A (en) * | 1991-04-24 | 1995-08-29 | Yamasa Shuyu Kabushiki Kaisha | 1-β-D-arabinofuranosyl-(E)-5-(2-halogenovinyl)uracil derivatives |
| CA2243237C (fr) * | 1996-01-19 | 2008-09-02 | Glaxo Group Limited | Utilisation de valaciclovir dans la fabrication d'un medicament destine au traitement de l'herpes genital |
-
2001
- 2001-01-03 IT IT2001MI000009A patent/ITMI20010009A1/it unknown
- 2001-04-25 IE IE20010413A patent/IE20010413A1/en not_active IP Right Cessation
- 2001-05-01 GB GB0110682A patent/GB2370771A/en not_active Withdrawn
- 2001-05-11 HR HR20010345A patent/HRPK20010345B3/xx not_active IP Right Cessation
- 2001-05-29 CH CH00987/01A patent/CH695662A5/de not_active IP Right Cessation
- 2001-06-28 SE SE0102309A patent/SE0102309L/ not_active Application Discontinuation
- 2001-06-29 DK DKPA200101019A patent/DK177084B1/da not_active IP Right Cessation
- 2001-06-29 FR FR0108596A patent/FR2818907B1/fr not_active Expired - Lifetime
- 2001-07-02 NL NL1018431A patent/NL1018431C2/nl not_active IP Right Cessation
- 2001-07-03 FI FI20011446A patent/FI20011446A7/fi not_active Application Discontinuation
- 2001-07-04 BE BE2001/0452A patent/BE1014522A5/fr not_active IP Right Cessation
- 2001-07-04 CZ CZ20012464A patent/CZ20012464A3/cs unknown
- 2001-07-04 UA UA2001074658A patent/UA76402C2/uk unknown
- 2001-07-04 SK SK957-2001A patent/SK287043B6/sk not_active IP Right Cessation
- 2001-07-05 HU HU0102816A patent/HUP0102816A3/hu unknown
- 2001-07-05 GR GR20010100322A patent/GR1004012B/el unknown
- 2001-07-05 PT PT102642A patent/PT102642B/pt active IP Right Grant
- 2001-07-05 ES ES200101566A patent/ES2192456B1/es not_active Expired - Fee Related
- 2001-07-05 PL PL01348480A patent/PL348480A1/xx not_active Application Discontinuation
-
2002
- 2002-07-03 AT AT0805702U patent/AT6141U1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CH695662A5 (de) | 2006-07-31 |
| FI20011446L (fi) | 2002-07-04 |
| CZ20012464A3 (cs) | 2002-08-14 |
| FR2818907A1 (fr) | 2002-07-05 |
| ES2192456B1 (es) | 2005-02-01 |
| GB0110682D0 (en) | 2001-06-20 |
| HRP20010345A2 (en) | 2003-08-31 |
| IE20010413A1 (en) | 2003-04-16 |
| PL348480A1 (en) | 2002-07-15 |
| AT6141U1 (de) | 2003-05-26 |
| HRPK20010345B3 (en) | 2005-02-28 |
| FI20011446A7 (fi) | 2002-07-04 |
| ITMI20010009A1 (it) | 2002-07-03 |
| DK177084B1 (da) | 2011-07-11 |
| GR1004012B (el) | 2002-11-01 |
| FI20011446A0 (fi) | 2001-07-03 |
| GR20010100322A (el) | 2002-10-08 |
| FR2818907B1 (fr) | 2006-05-26 |
| DK200101019A (da) | 2002-07-04 |
| SK9572001A3 (en) | 2003-03-04 |
| ITMI20010009A0 (it) | 2001-01-03 |
| UA76402C2 (en) | 2006-08-15 |
| HU0102816D0 (en) | 2001-09-28 |
| PT102642A (pt) | 2002-07-31 |
| BE1014522A5 (fr) | 2003-12-02 |
| ES2192456A1 (es) | 2003-10-01 |
| SK287043B6 (sk) | 2009-10-07 |
| NL1018431C2 (nl) | 2002-07-05 |
| GB2370771A (en) | 2002-07-10 |
| PT102642B (pt) | 2003-06-30 |
| HUP0102816A2 (en) | 2002-10-28 |
| SE0102309D0 (sv) | 2001-06-28 |
| SE0102309L (sv) | 2002-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1450824A4 (fr) | Composition pharmaceutique | |
| EP1407785A4 (fr) | Compositions medicinales | |
| IL152659A0 (en) | Pharmaceutical composition | |
| GB0111597D0 (en) | Pharmaceutical compositions | |
| HUP0204555A3 (en) | Pharmaceutical composition | |
| HUP0303163A3 (en) | Tramadol-based pharmaceutical composition | |
| GB0117057D0 (en) | Pharmaceutical composition | |
| EP1398040A4 (fr) | Composition de medicament | |
| GB0129117D0 (en) | Pharmaceutical composition | |
| IL158236A0 (en) | Pharmaceutical compositions containing azithromycin and derivatives thereof | |
| IL154238A0 (en) | Pharmaceutical composition | |
| GB0116107D0 (en) | Pharmaceutical composition | |
| GB0104752D0 (en) | Pharmaceutical compositions | |
| GB0127805D0 (en) | Pharmaceutical composition | |
| PL370037A1 (en) | Pharmaceutical composition | |
| GB0114746D0 (en) | Medicinal composition | |
| IL153176A (en) | Phenylpiperazines and pharmaceutical compositions comprising them | |
| HUP0102816A3 (en) | Pharmaceutical composition containg brivudine | |
| GB0005382D0 (en) | Pharmaceutical composition | |
| GB2382302B (en) | Pharmaceutical compositions | |
| IL157411A0 (en) | Pharmaceutical composition | |
| GB0125061D0 (en) | Pharmaceutical composition | |
| HU0103049D0 (en) | Pharmaceutical composition | |
| GB0126732D0 (en) | Pharmaceutical compositions | |
| GB0102462D0 (en) | Pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |